A less common case of anti‐MDA5 and anti‐Ro52 antibody‐positive juvenile dermatomyositis complicated with macrophage activation syndrome

A less common case of anti‐MDA5 and anti‐Ro52 antibody‐positive juvenile dermatomyositis complicated with macrophage activation syndrome

Bibliographic Details
Main Authors:	Li Zhang, Haiqing Zhang, Shanshan Liu, Ning Zhang, Yun Wang
Format:	Article
Language:	English
Published:	Wiley 2024-03-01
Series:	Clinical Case Reports
Subjects:	anti‐MDA5 antibody anti‐Ro52 antibody interstitial lung disease juvenile dermatomyositis macrophage activation syndrome
Online Access:	https://doi.org/10.1002/ccr3.8613

Similar Items

Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody
by: Huyan Wang, et al.
Published: (2023-07-01)

A Case of Dermatomyositis with Coexistence of Positive Anti-MDA5 Antibodies and Anti-SSA/RO52 Antibodies, Combined with Necrotic Skin Ulcers
by: Sun T, et al.
Published: (2024-01-01)

Dissociating Autoantibody Responses against Ro52 Antigen in Patients with Anti-Synthetase or Anti-MDA5 Antibodies
by: Akira Yoshida, et al.
Published: (2023-12-01)

Clinical Features and Prognosis of Double-Positive Anti-MDA5 and Anti-CCP Antibodies in Dermatomyositis: A Retrospective Study
by: Xu X, et al.
Published: (2025-02-01)

Fast-Onset Diffuse Interstitial Lung Disease in Anti-MDA5 Antibodies-Associated Amyopathic Dermatomyositis
by: Houari Aissaoui, et al.
Published: (2021-04-01)

Clinical features and survival analysis of 40 cases of anti-MDA5 antibody-positive dermatomyositis complicated with interstitial lung disease
by: Kaikai Zhao, et al.
Published: (2025-02-01)

Anti-MDA5 Amyopathic Dermatomyositis—A Diagnostic and Therapeutic Challenge
by: Anca Bobirca, et al.
Published: (2022-07-01)

Panniculitis in Anti-MDA-5 Positive Juvenile Dermatomyositis: A Case Report
by: Semra Ayduran, et al.
Published: (2024-12-01)

Successful treatment of an anti-MDA5 antibody-positive Juvenile Dermatomyositis patient with refractory interstitial lung disease using tofacitinib
by: Valentina Natoli, et al.
Published: (2025-02-01)

Case report: Successful treatment of anti‐MDA5‐positive to negative dermatomyositis‐associated interstitial lung disease with the JAK inhibitor tofacitinib
by: Zong Jiang, et al.
Published: (2023-06-01)

14-month-old female with anti-MDA5 juvenile dermatomyositis complicated by liver disease: a case report
by: Mitchell Kinkor, et al.
Published: (2024-09-01)

Association of anti-Ro-52 antibodies with occurrence of interstitial lung disease in patients with idiopathic inflammatory myopathy
by: Chia-Tse Weng, et al.
Published: (2024-08-01)

Comparison of characteristics and anti-MDA5 antibody distribution and effect between clinically amyopathic dermatomyositis and classic dermatomyositis: a retrospective case-control study
by: Qiang Ji, et al.
Published: (2023-11-01)

An amyopathic presentation of anti-PL-7 antisynthetase syndrome
by: K. D. R. S. Wijesena, et al.
Published: (2025-03-01)

Anti-NXP2 antibody positive dermatomyositis presenting as unilateral heliotrope rash
by: Zeinab F. Saleh, MD, et al.
Published: (2024-08-01)

Successful tocilizumab treatment for rapidly progressive interstitial lung disease with anti-MDA5-positive juvenile dermatomyositis: a case report and literature review
by: Lingzhi Qiu, et al.
Published: (2024-11-01)

Increased serum level of IL-6 predicts poor prognosis in anti-MDA5-positive dermatomyositis with rapidly progressive interstitial lung disease
by: Yuanyuan Niu, et al.
Published: (2024-10-01)

Clinical features and prognostic factors of anti‐melanoma differentiation‐associated gene 5 antibody‐positive dermatomyositis with rapidly progressive interstitial lung disease in Chinese patients
by: Li Lian, et al.
Published: (2023-06-01)

Dysregulated CD38 expression on T cells was associated with rapidly progressive interstitial lung disease in anti-melanoma differentiation-associated gene 5 positive dermatomyositis
by: Yixue Guo, et al.
Published: (2024-11-01)

Managing a Case of Refractory Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Associated Dermatomyositis with Recent COVID-19 Infection
by: Cheryl Chun Man Ng, et al.
Published: (2023-07-01)

Case report: Antisynthetase syndrome with positive anti-PL7/SSA/RO52 antibodies
by: Peng Ding, et al.
Published: (2024-09-01)

Clinical characteristics of anti-SRP antibody positive immune-mediated necrotizing myopathy with anti-TRIM21/Ro52 antibody positive
by: XU Li, GAO Huajie, YANG Mengge, LI Yue, JI Suqiong
Published: (2023-06-01)

Clinical features associated with the presence of anti-Ro52 and anti-Ro60 antibodies in Jo-1 antibody-positive anti-synthetase syndrome
by: Koichi Yamaguchi, et al.
Published: (2024-06-01)

Neutrophil-to-lymphocyte ratio and short-term mortality in patients having anti-MDA5-positive dermatomyositis with interstitial lung disease: a retrospective study
by: Hongxia Xin, et al.
Published: (2025-01-01)

Serum progranulin level is a novel tool for monitoring disease activity of dermatomyositis with antimelanoma differentiation‐associated protein 5 antibodies
by: Asami Fujii, et al.
Published: (2021-06-01)

Research progress of clinical effects of anti-Ro52/TRIM21 antibody in connective tissue diseases
by: YAN Ting-ting, XUE Jing
Published: (2021-09-01)

Infection Risk in Patients with Dermatomyositis Associated with Anti-MDA5 Antibodies: A Historical Cohort Study
by: Anne-Claire Billet, et al.
Published: (2022-12-01)

Amyopathic dermatomyositis with a rapidly progressing interstitial pneumonia
by: Darija Logvinova, et al.
Published: (2024-11-01)

Rapid and sustained response to JAK inhibition in a child with severe MDA5 + juvenile dermatomyositis
by: Timmy Strauss, et al.
Published: (2023-09-01)

A fatal interstitial lung disease in an anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody negative patient with juvenile dermatomyositis
by: Osman Yeşilbaş, et al.
Published: (2021-10-01)

Successful treatment of rapidly progressive interstitial lung disease complicated by a refractory pneumomediastinum in a patient with anti‐MDA5 antibody‐positive dermatomyositis
by: Lili Jiang, et al.
Published: (2023-12-01)

Monocyte–macrophage dynamics as key in disparate lung and peripheral immune responses in severe anti‐melanoma differentiation‐associated gene 5‐positive dermatomyositis‐related interstitial lung disease
by: Jia Shi, et al.
Published: (2025-02-01)

Disease-associated immune cell endotypes in anti-MDA5-positive dermatomyositis using unbiased hierarchical clustering
by: Ruru Guo, et al.
Published: (2024-03-01)

Lung infection or inflammation-a puzzling case of MDA-5 associated juvenile dermatomyositis
by: Anusha Vuppala, et al.
Published: (2023-12-01)

The interconnected roles of TRIM21/Ro52 in systemic lupus erythematosus, primary Sjögren’s syndrome, cancers, and cancer metabolism
by: Chueh-Hsuan Hsu, et al.
Published: (2023-11-01)

Wong-type dermatomyositis with interstitial lung disease and anti-SRP and -PM/Scl antibodies treated with intravenous immunoglobulin
by: Eric H. Kowalski, MD, et al.
Published: (2023-11-01)

Case Report: Contiguous presentation of anti-MDA5 juvenile dermatomyositis and anti-AQP4 neuromyelitis optica spectrum disorder in an adolescent patient
by: Rebecca E. Wiersma, et al.
Published: (2024-06-01)

Proteomic profiling identifies SPP1 associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis
by: Yulu Qiu, et al.
Published: (2024-01-01)

Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis—an exploratory study
by: Viggo Hamberg, et al.
Published: (2023-09-01)

Antimelanoma differentiation-associated gene 5 (anti-MDA5) antibody-positive dermatomyositis: clinical features and outcomes in a racially diverse patient cohort
by: Sai K. Koyoda, et al.
Published: (2025-01-01)